CSF N-Glycan Profiles to Investigate Biomarkers in Brain Developmental Disorders: Application to Leukodystrophies Related to eIF2B Mutations

• Anne Fogli ,

  Contributed equally to this work with: Anne Fogli, Christine Merle

  * E-mail: anne.fogli@inserm.u-clermont1.fr

  Affiliations Laboratoire GReD UMR INSERM U931 CNRS 6247, Faculté de Médecine, Clermont-Ferrand, France, Service de Biochimie Médicale, CHU de Clermont-Ferrand, Clermont-Ferrand, France

  ⨯
• Christine Merle ,

  Contributed equally to this work with: Anne Fogli, Christine Merle

  Affiliation Proteodynamics, Biopôle Clermont-Limagne, Saint-Beauzire, France

  ⨯
• Véronique Roussel,

  Affiliation Proteodynamics, Biopôle Clermont-Limagne, Saint-Beauzire, France

  ⨯
• Raphael Schiffmann,

  Affiliation Institute of Metabolic Disease, Baylor Research Institute, Dallas, Texas, United States of America

  ⨯
• Sylvie Ughetto,

  Affiliation Département d'Information Médicale, CHU de Clermont-Ferrand, Clermont-Ferrand, France

  ⨯
• Manfred Theisen,

  Affiliation Proteodynamics, Biopôle Clermont-Limagne, Saint-Beauzire, France

  ⨯
• Odile Boespflug-Tanguy

  Affiliations Laboratoire GReD UMR INSERM U931 CNRS 6247, Faculté de Médecine, Clermont-Ferrand, France, Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, Service de Neuropédiatrie et Maladies Métaboliques, centre de référence « leucodystrophies », Paris, France, Université Paris Diderot, Sorbonne Cité, Paris, France

  ⨯